Denali Therapeutics Inc. Stock Agreements
12 Contracts & Agreements
- Description of the Registrants Common Stock (Filed With SEC on February 28, 2024)
- Description of the Registrants Common Stock (Filed With SEC on February 27, 2023)
- Description of the Registrants Common Stock (Filed With SEC on February 28, 2022)
- Description of the registrants common stock (Filed With SEC on February 26, 2021)
- Standstill and Stock Restriction Agreement between the Registrant and Biogen Inc., dated September 22, 2020 (Filed With SEC on November 5, 2020)
- Common Stock Purchase Agreement between the Registrant and Biogen Inc., dated August 5, 2020 (Filed With SEC on November 5, 2020)
- Description of the registrants common stock (Filed With SEC on February 27, 2020)
- Standstill and Stock Restriction Agreement between the Registrant and Takeda Pharmaceutical Company Limited, dated February 23, 2018 (Filed With SEC on March 19, 2018)
- Common Stock Purchase Agreement between the Registrant and Takeda Pharmaceutical Company Limited, dated January 3, 2018 (Filed With SEC on March 19, 2018)
- 2017 Employee Stock Purchase Plan and form of agreement thereunder, to be in effect upon the completion of this offering (Filed With SEC on December 7, 2017)
- 2017 Employee Stock Purchase Plan and form of agreement thereunder, to be in effect upon the completion of this offering (Filed With SEC on November 27, 2017)
- Specimen common stock certificate of the Registrant (Filed With SEC on November 27, 2017)
